Glympse Bio

28 articles about Glympse Bio

• Pharmaceutical Executive Francis Cuss Joins Glympse Bio Board

  8/1/2019

  Glympse Bio, Inc., a life science company developing in vivo activity sensors to transform disease detection, monitoring and drug response, announced today that Francis Cuss has been appointed to its Board of Directors

• 

  BioSpace Movers and Shakers, May 17

  5/17/2019

  Biopharma companies add new leaders to executive roles and boards of directors.

• Glympse Bio, Inc. Names Wendy Winckler as Chief Scientific Officer

  5/14/2019

  Skilled Operational and Scientific Leader Brings More than 15 Years of Molecular Genetics Experience

• Glympse Bio, Inc. Named to FierceMedTech’s “Fierce 15”

  2/11/2019

  Glympse Bio, Inc., a life science company developing in vivo activity sensors to transform disease monitoring, announced today that it has been named by FierceMedTech as one of 2018’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry.

• 

  Top 10 Cities in the U.S. for the Job Market

  1/15/2019

  New Year, fresh start? Could be. WalletHub recently compared more than 180 cities across the U.S., using 30 key indicators to evaluate their job strength. Some of those factors were job opportunities, employment growth, monthly average starting salary and employment outlook.
• 

  BioSpace Movers and Shakers for Dec. 10

  12/10/2018

  Biotech and pharma companies strengthen their leadership teams with these appointments. Who made power moves in the industry this past week?

• Glympse Bio, Inc. Appoints Caroline J Loew, Ph.D. President and Chief Executive Officer

  12/4/2018

  Stanley Lapidus appointed as Chairman of the Board; Dr. Robert Langer appointed to the Board of the Directors; Co-Founder Dr. Sangeeta Bhatia to lead Scientific Advisory Board

• Glympse Bio, Inc. Raises $22m Series A Financing

  10/9/2018

  Top-Tier Investor Syndicate and Strategic Pharma Partner back a Novel Model for Sensing Diseases